PIA
ASTH icon

Piedmont Investment Advisors’s Astrana Health ASTH Stock Holding History

Piedmont Investment Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-430
Closed -$11K – 2330
2018
Q2 		$11K Buy
+430
New +$7.37K ﹤0.01% 1812

Other funds holding ASTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Piedmont Investment Advisors's ASTH Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Astrana Health (ASTH) in Q3 2018, closing a stake of 430 shares — an estimated $11K sold.

Piedmont Investment Advisors first reported a position in ASTH in Q2 2018 and held it in 1 quarter. The position peaked at $11K in Q2 2018. 36 funds tracked by Wall St. Rank hold ASTH as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Astrana Health position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 430 Astrana Health shares in Q3 2018, an estimated $11K.
  • Piedmont Investment Advisors first reported a position in Astrana Health in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Astrana Health position peaked at $11K in Q2 2018.
  • 36 funds tracked by Wall St. Rank held Astrana Health as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.